These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 31631856)

  • 1. A double blow for a patient with leprosy: a reversal reaction and an adverse drug reaction.
    Thangaraju P; Venkatesan S
    Lancet; 2019 Oct; 394(10207):1450. PubMed ID: 31631856
    [No Abstract]   [Full Text] [Related]  

  • 2. Acute Generalized Exanthematous Pustulosis (AGEP) due to dapsone in a patient with leprosy.
    Narasimharao P; Pratap DV; Suneetha S
    Lepr Rev; 2009 Mar; 80(1):81-4. PubMed ID: 19472855
    [No Abstract]   [Full Text] [Related]  

  • 3. Dapsone agranulocytosis in a leprosy patient.
    Hiran S; Pande TK; Pani S; Vishwanathan KA
    Lepr Rev; 1994 Sep; 65(3):279-81. PubMed ID: 8942159
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dapsone-associated fixed drug eruption.
    Garcia D; Cohen PR
    Expert Rev Clin Pharmacol; 2017 Jul; 10(7):717-725. PubMed ID: 28434260
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dapsone-induced eosinophilic pneumonitis in a leprosy patient.
    Kaur J; Khandpur S; Seith A; Khanna N
    Indian J Lepr; 2005; 77(3):267-71. PubMed ID: 16353525
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dapsone-induced agranulocytosis in a patient of leprosy.
    Mishra M; Chhetia R
    Indian J Dermatol Venereol Leprol; 2006; 72(6):456-7. PubMed ID: 17179627
    [No Abstract]   [Full Text] [Related]  

  • 7. Steroid therapy and leprosy.
    Ramu G
    Indian J Lepr; 1996; 68(2):182-3. PubMed ID: 8835589
    [No Abstract]   [Full Text] [Related]  

  • 8. Dapsone syndrome.
    Dhamija R; Kumar D; Khurana G
    Trop Doct; 1995 Oct; 25(4):176-7. PubMed ID: 7502329
    [No Abstract]   [Full Text] [Related]  

  • 9. Dapsone syndrome with acute renal failure during leprosy treatment: case report.
    Alves-Rodrigues EN; Ribeiro LC; Silva MD; Takiuchi A; Fontes CJ
    Braz J Infect Dis; 2005 Feb; 9(1):84-6. PubMed ID: 15947852
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between HLA-B*1301 and dapsone-induced hypersensitivity reactions among leprosy patients in China.
    Wang H; Yan L; Zhang G; Chen X; Yang J; Li M; Shen J; Yu M; Huo R; Wang B
    J Invest Dermatol; 2013 Nov; 133(11):2642-2644. PubMed ID: 23604100
    [No Abstract]   [Full Text] [Related]  

  • 11. Dapsone-induced methemoglobinemia in leprosy patients.
    Kaur I; Mehta M; Agnihotri N; Dogra S; Ganguly NK
    Int J Lepr Other Mycobact Dis; 2001 Sep; 69(3):247-9. PubMed ID: 11875770
    [No Abstract]   [Full Text] [Related]  

  • 12. Mortality due to dapsone hypersensitivity syndrome complicating multi-drug therapy for leprosy in Nepal.
    Pandey B; Shrestha K; Lewis J; Hawksworth RA; Walker SL
    Trop Doct; 2007 Jul; 37(3):162-3. PubMed ID: 17716505
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hemolytic anemia in patients receiving daily dapsone for the treatment of leprosy.
    Deps P; Guerra P; Nasser S; Simon M
    Lepr Rev; 2012 Sep; 83(3):305-7. PubMed ID: 23356031
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A retrospective study of the effect of modified multi-drug therapy in Nepali leprosy patients following the development of adverse effects due to dapsone.
    Sapkota BR; Shrestha K; Pandey B; Walker SL
    Lepr Rev; 2008 Dec; 79(4):425-8. PubMed ID: 19274989
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Urinary tract carcinoma in leprosy patients treated with dapsone for a long period.
    Hironaka K; Mizushima M; Tsuzi C; Makino H
    Nephron; 1997; 76(3):358-9. PubMed ID: 9226243
    [No Abstract]   [Full Text] [Related]  

  • 16. Dapsone hypersensitivity syndrome with coexisting acute hepatitis E.
    Chogle A; Nagral A; Soni A; Agale S; Jamadar Z
    Indian J Gastroenterol; 2000; 19(2):85-6. PubMed ID: 10812824
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fatal dapsone hypersensitivity syndrome with hypothyroidism and steroid-induced diabetes mellitus.
    Pai S; Munshi R; Nayak C
    Indian J Pharmacol; 2017; 49(5):396-398. PubMed ID: 29515281
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypersensitivity reactions to dapsone: a systematic review.
    Lorenz M; Wozel G; Schmitt J
    Acta Derm Venereol; 2012 Mar; 92(2):194-9. PubMed ID: 22307940
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dapsone-induced acute myopia.
    Gopalani VV; More AS
    Indian J Dermatol Venereol Leprol; 2006; 72(6):455-6. PubMed ID: 17179626
    [No Abstract]   [Full Text] [Related]  

  • 20. Dapsone-induced haemolytic anaemia, hepatitis and agranulocytosis in a leprosy patient with normal glucose-6-phosphate-dehydrogenase activity.
    Ranawaka RR; Mendis S; Weerakoon HS
    Lepr Rev; 2008 Dec; 79(4):436-40. PubMed ID: 19274991
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.